- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03630510
Ventilator Hyperinflation With Increase of Inspiratory Time
August 9, 2018 updated by: Luciano Matos Chicayban, Brazilian Institute of Higher Education of Censa
Ventilator Hyperinflation With Increase of Inspiratory Time on Respiratory Mechanics: A Randomized Crossover Trial
The investigators hypothesis is that the adjustment of the inspiratory time may optimize the distribution of ventilation and increase tidal volume, producing potential therapeutic effects on the displacement of secretions and respiratory mechanics.
The objective of this study was To evaluate the effects of hyperinflation with the ventilator associated with increased inspiratory time on respiratory mechanics.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A randomized crossover clinical trial was conducted with 38 mechanically ventilated patients with pulmonary infection.
The order of hyperinflation or control (without changes in parameters) was randomized.
Hyperinflation was performed for 5 minutes in the controlled pressure ventilation mode, with progressive increases of 5cmH2O until reaching a maximum pressure of 35cmH2O, maintaining PEEP.
After reaching 35cmH2O, the inspiratory time and respiratory rate were adjusted so that the inspiratory and expiratory flows reached the baseline, respectively.
Static compliance (Cest, sr), total resistance (Rsr) and airway resistance (Rva), slow pressure drop (ΔP2) and peak expiratory flow (PEF) were assessed before (PRÉ), immediately after the maneuver (POSSimed) and after aspiration (POSPasp).
Two-way ANOVA was used for repeated measurements with Tukey post-test, considering a significant p <0.05.
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
RJ
-
Campos Dos Goytacazes, RJ, Brazil, 28015150
- Luciano M Chicayban
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients under mechanical ventilation for more than 48h
- Mucus hypersecretion (defined as the need for suctioning < 2-h intervals)
Exclusion Criteria:
- Severe bronchospasm,
- Positive end expiratory pressure > 10cmH2O,
- PaO2-FiO2 relationship < 150,
- Mean arterial pressure < 60mmHg,
- Pleural effusion or pneumothorax undrained,
- Bronchopleural or tracheoesophageal fistula,
- Decompensated congestive heart failure.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: mechanical ventilator hyperinflation
The VHI maneuver with inspiratory time adjustment was performed in the pressure controlled ventilation mode (PCV).
The inspiratory pressure was increased gradually every 5 cmH2O until reaching a maximum pressure of 35 cmH2O, according to the tolerance of the patient determined by the absence of cough.
PEEP remained unchanged throughout the study.
After reaching a maximum pressure of 35 cmH2O (PCV + PEEP level), the inspiratory time was gradually increased until the inspiratory flow reached the baseline.
Concomitantly, the respiratory rate was decreased to allow the expiratory flow also to reach the baseline, to avoid self-PEEP.
The maneuver was performed for 5 min, followed by tracheal aspiration.
|
The ventilator hyperinflation maneuver with inspiratory time adjustment was performed in the pressure controlled ventilation mode (PCV).
The inspiratory pressure was increased gradually every 5 cmH2O until reaching a maximum pressure of 35 cmH2O, according to the tolerance of the patient determined by the absence of cough.
PEEP remained unchanged throughout the study.
After reaching a maximum pressure of 35 cmH2O (PCV + PEEP level), the inspiratory time was gradually increased until the inspiratory flow reached the baseline.
Concomitantly, the respiratory rate was decreased to allow the expiratory flow also to reach the baseline, to avoid self-PEEP.
The maneuver was performed for 5 min, followed by tracheal aspiration.
|
No Intervention: Control
To perform the control (CTRL), the patients were only positioned and aspirated, without alteration in ventilatory parameters.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Static compliance of respiratory system
Time Frame: Baseline (before), immediately after VHI and five minutes after aspiration
|
Compliance was assessed through the occlusion maneuver at the end of inspiration, considering tidal volume, plateau pressure and PEEP.
Three measurements were taken at each moment, the mean being used.
|
Baseline (before), immediately after VHI and five minutes after aspiration
|
Total Resistance of respiratory system
Time Frame: Baseline (before), immediately after VHI and five minutes after aspiration
|
The total resistance of the respiratory system was evaluated through the occlusion maneuver at the end of the inspiration, considering the resistive pressure, measured by the difference between the maximum plateau pressure.
Three measurements were taken at each moment, the mean being used.
|
Baseline (before), immediately after VHI and five minutes after aspiration
|
Airway Resistance
Time Frame: Baseline (before), immediately after VHI and five minutes after aspiration
|
The airway resistance was assessed by means of the occlusion maneuver at the end of the inspiration, considering the rapid fall of the pressure immediately after the occlusion, measured by the difference between the maximum pressure and P1.
Three measurements were taken at each moment, the mean being used.
|
Baseline (before), immediately after VHI and five minutes after aspiration
|
Peak expiratory flow
Time Frame: Baseline (before), immediately after VHI and five minutes after aspiration
|
The peak expiratory flow was evaluated through passive expiration, being considered the greatest value of the flow in the expiratory phase.
|
Baseline (before), immediately after VHI and five minutes after aspiration
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: LUCIANO M CHICAYBAN, Brazilian Institute of Higher Education of Censa
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 18, 2017
Primary Completion (Actual)
August 12, 2017
Study Completion (Actual)
March 28, 2018
Study Registration Dates
First Submitted
March 2, 2017
First Submitted That Met QC Criteria
August 9, 2018
First Posted (Actual)
August 15, 2018
Study Record Updates
Last Update Posted (Actual)
August 15, 2018
Last Update Submitted That Met QC Criteria
August 9, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- VHI + Tins
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mechanical Ventilation
-
Thammasat UniversityCompletedProlonged Mechanical Ventilation | Home Mechanical VentilationThailand
-
JOSE IVAN RODRIGUEZ DE MOLINA SERRANOCompletedMechanical Ventilation Complication | Mechanical Power | Driving Pressure | Lung Protective VentilationMexico
-
Academisch Medisch Centrum - Universiteit van Amsterdam...University of Zurich; Dijklander Ziekenhuis; Reinier de Graaf GroepCompletedMechanical Ventilation | Mechanical PowerNetherlands
-
Rabin Medical CenterUnknownMechanical Ventilation | Weaning | Prolonged Ventilation
-
Drägerwerk AG & Co. KGaAUniversity of Göttingen; Prof. Dr. med. ImhoffSuspendedMechanical Ventilation | Ventilation Perfusion MismatchGermany
-
Capital Medical UniversityRecruitingMechanical VentilationChina
-
University of ChicagoActive, not recruitingMechanical VentilationUnited States
-
Chang Gung UniversityCompleted
-
The University of Texas Health Science Center,...Edwards LifesciencesWithdrawnMechanical VentilationUnited States
-
Bursa Yüksek İhtisas Education and Research HospitalCompletedthe Effect of Different Mechanical Ventilation Modes on Optic Nerve Diameter and Conscious FunctionsMechanical VentilationTurkey
Clinical Trials on Ventilator hyperinflation
-
Hospital de Clinicas de Porto AlegreUnknown
-
Khon Kaen UniversityCompleted
-
Khon Kaen UniversityUnknown
-
Brazilian Institute of Higher Education of CensaCompletedPulmonary Atelectasis
-
Foundation University IslamabadCompleted
-
University of Texas Southwestern Medical CenterRecruitingPostoperative Complications | Pulmonary DiseaseUnited States
-
Federal University of São PauloCompletedCOPD Patients | Dynamic Lung Hyperinflation | Activities of Daily Livin.Brazil
-
Universidade Federal de Sao CarlosActive, not recruitingHypoventilation | HypoxemiaBrazil
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknownCritically Injured Mechanically Ventilated Trauma PatientsAustralia
-
University of Lausanne HospitalsCompletedRespiratoy Failure Requiring NIV TreatmentSwitzerland